Genetic and epidemiologic studies have demonstrated that elevated serum levels of Lp(a) increase risk for atherosclerotic vascular disease (ASCVD), with guidelines suggesting that levels ≥50 mg/dL or ≥125 nmol/L be used as a risk-enhancing factor when adjudicating ASCVD risk (1). Here, LPA is linked to atherosclerosis.